Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310-1316. doi:10.1093/jnci/91.15.1310 [6]Johannsson O, Loman N, Möller T, Kristoffersson U, Borg A, Olsson H. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J...
Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium. J Natl Cancer Inst 1999;91:1310-16.The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91:1310-1316.The Breast Cancer Linkage Consortium (1999) Cancer risks in ...
参考文献: Schrijver LH, Mooij TM, Pijpe A, et al. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. J Natl cancer Inst. 2022 Apr 11;114(4):540-552. doi: 10.1093/jnci/djac004.
Cancer risks among BRCA1 and BRCA2 mutation carriers. British journal of cancer 2007; 96:11-5. DOI: 10.1038/sj.bjc.6603535. PMID: 17213823. 20.Slade D. PARP and PARG inhibitors in cancer treatment. Genes & develo...
近日,求臻医学与青岛市中心医院放疗科张小涛主任合作,首次报道了一例有BRCA2胚系移码突变(NM_000059.3:exon11: c.4563_4564delAT: L1522fs)的难治性转移性纵隔卵黄囊瘤患者对局部放疗有显著反应。目前该案例报道(case report)已在线发表于Cancer Biology & Therapy(IF:4.742)。
[5]Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310-1316. doi:10.1093/jnci/91.15.1310 [6]Johannsson O, Loman N, Möller T, Kristoffersson U, Borg A, Olsson H. Incidence of malignant tumours in relatives of BRCA1 and BRCA...
1. Wooster R, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.Science, 1994. 2. Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers.J Natl Cancer Inst,1999. 3. Tutt ANJ, et al. Adjuvant Olaparib for Patients with BRCA1-...
近日,求臻医学与青岛市中心医院放疗科张小涛主任合作,首次报道了一例有BRCA2胚系移码突变(NM_000059.3:exon11: c.4563_4564delAT: L1522fs)的难治性转移性纵隔卵黄囊瘤患者对局部放疗有显著反应。目前该案例报道(case report)已在线发表于Cancer Biology & Therapy(IF:4.742)。
近日,求臻医学与青岛市中心医院放疗科张小涛主任合作,首次报道了一例有BRCA2胚系移码突变(NM_000059.3:exon11: c.4563_4564delAT: L1522fs)的难治性转移性纵隔卵黄囊瘤患者对局部放疗有显著反应。目前该案例报道(case report)已在线发表于Cancer Biology & Therapy(IF:4.742)。
This cohort study estimates age-specific risks of breast, ovarian, and contralateral breast cancer among carriers of BRCA1 and BRCA2 mutations and